Day One Biopharmaceuticals, Inc.

Contributing Author

Recent Articles by Day One Biopharmaceuticals, Inc.

Nov-13	Day One to Acquire Mersana Therapeutics to Advance Mission to Bring New Medicines to People of All Ages with Life-Threatening Diseases DAWN -14.41% GlobeNewswire
Nov-10	Day One Announces New OJEMDA (tovorafenib) Data to be Presented in Oral Session at the 2025 Society for Neuro-Oncology (SNO) Annual Meeting DAWN GlobeNewswire
Nov-04	Day One Reports Third Quarter 2025 Financial Results and Corporate Progress DAWN GlobeNewswire
Oct-21	Day One to Report Third Quarter 2025 Financial Results Tuesday, November 4, 2025 DAWN GlobeNewswire
Aug-05	Day One Reports Second Quarter 2025 Financial Results and Corporate Progress DAWN GlobeNewswire
Jul-22	Day One to Report Second Quarter 2025 Financial Results Tuesday, August 5, 2025 DAWN GlobeNewswire
Jun-10	Day One Appoints Michael Vasconcelles, M.D., as Head of Research and Development DAWN GlobeNewswire
May-06	Day One Reports First Quarter 2025 Financial Results and Corporate Progress DAWN GlobeNewswire